North Central London Cancer Alliance’s Post

This Sunday, February 4th is World Cancer Day, an initiative of the Union for International Cancer Control (UICC) to take action to promote health equity, enhance cancer service accessibility, and #CloseTheCareGap. Visit their website to learn more and sign the call to action! --> https://lnkd.in/dYiwh8xA Bruker’s fluorescent microscopes are used in labs around the world working to better understand the mechanisms underlying various forms of cancer. Specific applications include the Ultima multiphoton system being used to investigate anti-tumor immunity in poor prognosis cancers or the Luxendo InVi SPIM light-sheet system helping to unravel breast cancer evolution and potential treatments. ⬇️Characterization and imaging of stochastic tumorigenesis in mammary organoids. #WorldCancerDay #CancerResearch #CancerAwareness

Game-changing news in rare cancer research! 🔬 Researchers from the International Agency for Research on Cancer have achieved a groundbreaking milestone in understanding rare cancers. They've developed "mini-tumours," a revolutionary tool that mirrors the complexity of rare cancers in a controlled environment. This innovation offers a new window into cancer progression and opens up possibilities for designing more effective clinical interventions. Why is this important? These mini-tumours preserve the unique characteristics of the original tumors, allowing researchers to study them in unprecedented detail. This means a better understanding of how rare cancers evolve and respond to treatments, bringing us closer to personalized medicine for those facing these challenging diagnoses. Your ongoing support and interest are what drive these scientific breakthroughs! Together, let's continue to make strides in rare cancer research and care. 🌟 Read more about this incredible advancement here: https://lnkd.in/gd63a_Wb #RareCancerResearch #Innovation #MiniTumours #JediRareCancerFoundation #RaiseAwareness #MakingADifference #DonateToday #FightAgainstRareCancers #RareCancerIsntRare

On World Breast Cancer Research Day, we honor the incredible strength and resilience of those affected by breast cancer and reaffirm our commitment to advancing research in this critical field. At SHRO, our scientists are at the forefront of discovering new treatment strategies and understanding the molecular mechanisms that drive breast cancer. Every breakthrough brings us closer to a world where breast cancer is no longer a threat. Join us in supporting the vital research that offers hope and healing to millions. Together, we can make a difference. Check out our most recent blog on how artificial intelligence is transforming the screening and diagnosis of breast cancer Link to the Italian blog: https//bit.ly/4bO7aPF Link to the English Blog: https://bit.ly/3Y8PZp5 www.drantoniogiordano.com | www.shro.org Antonio Giordano Sbarro Health Research Organization Temple University Università di Siena #BreastCancerResearchDay #CancerResearch #HopeForACure #SHRO #WorldBreastCancerResearchDay #BreastCancerAwareness #BreastCancerResearch #FindACure #HopeForACure #CancerResearch #SupportTheFight #EndBreastCancer #SHROResearch #TogetherWeCan #BreastCancerSurvivors #ResearchForHope

Good to see Genomics England's latest research on cancer genomics published today in Nature Medicine - the largest of its kind study into the whole genomes of 13,000 cancer patients in England - showing the true potential of precision oncology to better tailor care. However, set against this, we also saw new analysis showing the UK has some of the worst cancer outcomes in the developed world. We need to plug the gap between pioneering R&I and translation, to improve outcomes and bring us in line with international colleagues. I'm looking forward to seeing what the next year brings the cancer community in terms of urgently needed government policy and manifesto commitments - a cancer strategy perhaps? GEL paper here: https://lnkd.in/erjsn-eg, and coverage here: https://lnkd.in/epDpZt74 Cancer outcomes coverage here: https://lnkd.in/eF_wJjk8

Great to have Dr. Allie Grossmann as a member of the team and in the lab adjoining mine at the Earle A. Chiles Research Institute & Providence Cancer Institute. From our early discussions I believe there are many opportunities for us to collaborate. On this #WorldCancerResearchDay It is more clear than ever that we all need to work togetther to #FinishCancer. This includes #academics, #biotechs, #pharma, #regulators, & #investors from #VCs & #FamilyOffices. #cancer #immunotherapy

Dr. Laura Hopkins (Saskatchewan Cancer Agency & University of Saskatchewan) is a gynecologic oncologist and cancer researcher, who leads a clinical trial measuring how patients with #ovariancancer use information from molecular tumour testing to guide treatment decisions based on quality of life and outcome considerations. This study, which is contributing cases to the MOHCCN Gold Cohort, will provide an important step towards measuring the real-world impact of precision oncology on the lives of cancer patients. For our latest #ResearcherProfile, we spoke to Dr. Hopkins to learn more about her research and clinical work, how precision oncology can help empower patients to make decisions about their own care based on their values and preferences and how the Network is bringing together clinicians, patients and basic scientists to improve connectivity between cancer research and care. We really think this one is a must-read to better understand the multiple layers of #precisionmedicine. Read now ▶ https://lnkd.in/eb-c3K_4 #TeamCanadaOfCancerResearch The Terry Fox Research Institute The Terry Fox Foundation Health Canada | Santé Canada

📊 This week is an occasion to recognise the critical role that cutting-edge studies and data play in cancer care. In recent years, European research has contributed significant advances in hereditary cancers, early detection of multi-cancers, and personalised medicine. The #EUCancerPlan and #EUCancerMission must be refreshed to reflect the latest science. Read more ➡️ https://lnkd.in/eAbCZciG #PublicHealth #WorldCancerResearchDay #CancerResearch #CancerData #EUCancerRoadmap | Union for International Cancer Control (UICC) | Association of European Cancer Leagues | EORTC - European Organisation for Research and Treatment of Cancer

A research team led by Dr Lisa Mielke at La Trobe's School of Cancer Medicine, the Olivia Newton-John Cancer Research Institute, have made a discovery that holds great potential for treating one of the world's most prominent forms of cancer. The team found that patients whose bowel cancer tumours showed evidence of a particular type of immune cell (known as a 'gamma delta t-cell') had much better health outcomes. This led researchers to take a closer look at gamma delta t-cells to better understand how to harness and enhance their cancer-killing potential. The research - shortlisted for a prestigious Australian Museum Eureka Prize for Scientific Resarch - may pave the way for new immunotherapies that improve health outcomes and save the lives of countless cancer patients. Learn more: https://lnkd.in/gxzmbHh5 #cancer #medicalresearch #latrobeuni #onjcri

As Breast Cancer Awareness Month unfolds, let's take a moment to reflect on the ongoing battle against breast cancer and the groundbreaking research being done in the field. At CellSave, we believe that the key to overcoming this disease may lie in the incredible potential of stem cells. Did you know that breast cancer stem cells have been identified as a potential driver of cancer development and metastasis? By understanding and targeting these cells, researchers hope to develop more effective treatments and improve patient outcomes. As we continue to make strides in the fight against breast cancer, let's also celebrate the resilience and strength of the women affected by this disease. Together, we can work towards a brighter, healthier future for all. #BreastCancerAwarenessMonth #StemCellResearch #WomenEmpowerment #CellSave #FightAgainstCancer

📢 Major Leap in Cancer Research! 🌐 Thrilled to share our latest publication in the European Journal of Cancer. A massive round of applause to the brilliant minds behind this – Carmen Martos Jiménez, Florentino Caetano dos Santos, Francesco Giusti, Henna Degerlund, Neamtiu Luciana, Lukasz Taraszkiewicz, Liesbet Van Eycken, and Otto Visser! 🎉 Our letter delves into the 2023 Revised European Network of Cancer Registries Recommendations for Standard Dataset, a game-changer in cancer data analysis. 🚀 Unveiling a paradigm shift, these guidelines redefine how we gather and interpret data in European oncology. Let's keep pushing boundaries in cancer research! 💪🔬 #CancerResearch #DataRevolution #ENCRRecommendations https://lnkd.in/drTnprGh